Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Nuclear Medicine

• Publication date

  2000-10-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s002590000367PMID 24578007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FDG Uptake , GLUT-i Glucose Transporterand Cellularity in Human Pancreatic Tumors

  2006cited by this paper
• FDG PET measurement of the proliferative potential of non-small cell lung cancer.

  2000cited by this paper
• Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.

  1999cited by this paper
• Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.

  1999cited by this paper
• Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells.

  1999cited by this paper
• Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.

  1999cited by this paper
• Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.

  1998cited by this paper
• Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.

  1998cited by this paper
• Enhancement of ATP Levels and Glucose Metabolism during an Infection by Chlamydia

  1998cited by this paper
• Localized form of bronchioloalveolar carcinoma: FDG PET findings.

  1998cited by this paper
• Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.

  1998cited by this paper
• Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.

  1998cited by this paper
• The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.

  1998cited by this paper
• Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.

  1998cited by this paper
• Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

  1997cited by this paper
• Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

  1997cited by this paper
• Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival

  1997cited by this paper
• Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign.

  1996cited by this paper
• The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models.

  1996cited by this paper
• Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.

  1996cited by this paper
• Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.

  1996cited by this paper
• Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.

  1995cited by this paper
• Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

  1995cited by this paper
• Small adenocarcinoma of the lung. Histologic characteristics and prognosis

  1995cited by this paper
• GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.

  1995cited by this paper
• Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features

  1994cited by this paper
• Facilitative glucose transporters.

  1994cited by this paper
• Growth factors, mitogens, oncogenes and the regulation of glucose transport.

  1993cited by this paper
• The changing pattern of lung carcinoma

  1991cited by this paper
• Sequence and structure of a human glucose transporter.

  1985cited by this paper

• Advances in Inhaled Nanoparticle Drug Delivery for Pulmonary Disease Management

  2025cites this paper
• A Rare Case of High-Grade Fetal Adenocarcinoma of the Lung Demonstrated by 18F-FDG PET/CT.

  2024cites this paper
• [18F]FDG- PET/CT in Staging and Restaging of Fetal Type Adenocarcinoma of the Lung: A Case Report and a Review of the Literature

  2024cites this paper
• Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer.

  2024cites this paper
• Patlak Reconstruction Using Dynamic 18F-FDG PET Imaging for Evaluation of Malignant Liver Tumors

  2023cites this paper
• Direct co-registration of [^18F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study

  2023cites this paper
• Lung cancer detection with computer-aided diagnosis (CAD) for various methods, segmentation, classification and analysis: A review

  2023cites this paper
• Druggability of Targets for Diagnostic Radiopharmaceuticals.

  2023cites this paper
• Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection

  2023cites this paper
• The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma

  2023cites this paper
• Influences on PET Quantification and Interpretation

  2022cites this paper
• Preferential uptake of glucose-functionalized liposomes by cancer cells

  2022cites this paper
• Evaluation of the 18F-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma

  2022cites this paper
• 18F‐fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma

  2022cites this paper
• A Review of the Correlation Between Epidermal Growth Factor Receptor Mutation Status and 18F-FDG Metabolic Activity in Non-Small Cell Lung Cancer

  2022cites this paper
• The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells

  2021cites this paper
• Human papillomavirus16 E6 but not E7 upregulates GLUT1 expression in lung cancer cells by upregulating thioredoxin expression

  2021cites this paper
• AcidoCEST MRI Evaluates the Bone Microenvironment in Multiple Myeloma

  2021cites this paper
• Involvement of cancer-derived EMT cells in the accumulation of 18F-fluorodeoxyglucose in the hypoxic cancer microenvironment

  2021cites this paper
• Influx rate constant of 18F-FDG increases in metastatic lymph nodes of non-small cell lung cancer patients

  2020cites this paper
• 18F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfaces

  2020cites this paper
• Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma

  2020cites this paper
• Glucose-Functionalized Liposomes for Reducing False Positives in Cancer Diagnosis.

  2020cites this paper
• Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis

  2020cites this paper
• Does nutrition for cancer patients feed the tumour? A clinical perspective.

  2020cites this paper
• Correlations between the metabolic profile and 18F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients

  2019cites this paper
• Associations between GLUT expression and SUV values derived from FDG-PET in different tumors—A systematic review and meta analysis

  2019cites this paper
• Associations between FDG-PET and Ki 67-index in head and neck cancer

  2019cites this paper
• Anti-tumor effect of aloe-emodin on cervical cancer cells was associated with human papillomavirus E6/E7 and glucose metabolism

  2019cites this paper
• Cellular internalization pathways of glucose-functionalized gold nanoparticles

  2019cites this paper
• The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.

  2019cites this paper
• Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma

  2019cites this paper
• New insight on the correlation of metabolic status on 18F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer

  2019cites this paper
• The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism

  2019cites this paper
• 18 F-FDG PET/CT: Normal Variants, Artifacts, and Pitfalls in Lung Cancer

  2018cites this paper
• FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value.

  2018cites this paper
• Bronchioalveolar carcinoma: Role of Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in detection of its recurrence and verifying its subtypes

  2018cites this paper
• Title Prediction of recurrence for non-small cell lung cancer by combined analysis of molecular markers and ^ { 18 } F 2-fluoro-2-deoxy-d-glucose positron emission tomography

  2018cites this paper
• Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules

  2018cites this paper
• Uptake mechanism of metabolic-targeted gold nanoparticles.

  2018cites this paper
• An Anti-tumorigenic Role of the Warburg Effect at Emergence of Transformed Cells.

  2018cites this paper
• Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET.

  2018cites this paper
• Standardized Uptake Values Derived from 18F-FDG PET May Predict Lung Cancer Microvessel Density and Expression of KI 67, VEGF, and HIF-1α but Not Expression of Cyclin D1, PCNA, EGFR, PD L1, and p53

  2018cites this paper
• SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma

  2017cites this paper
• Metabolic characteristics of programmed cell death‐ligand 1‐expressing lung cancer on 18F‐fluorodeoxyglucose positron emission tomography/computed tomography

  2017cites this paper
• Association Between PD-L1 Expression and Metabolic Activity on 18F-FDG PET/CT in Patients with Small-sized Lung Cancer.

  2017cites this paper
• Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma

  2017cites this paper
• Prognostic Role of ERCC 1 Protein Expression and its Correlation with 18 F-FDG Uptake on PET in Patients with Resected Non-Small Cell Lung Cancer

  2017cites this paper
• Radiopathological Features and Identification of Mycobacterial Infections in Granulomatous Nodules Resected from the Lung

  2017cites this paper
• Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept Study

  2017cites this paper
• The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition

  2017cites this paper
• FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription

  2016cites this paper
• Imaging and clinical outcome of non-small cell lung cancer

  2016cites this paper
• Warburg Effect - a Consequence or the Cause of Carcinogenesis?

  2016cites this paper
• Differentiating Between Cancer and Inflammation: A Metabolic-Based Method for Functional Computed Tomography Imaging.

  2016cites this paper
• Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in 18fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer

  2016cites this paper
• Unusual False-Positive Mesenteric Lymph Nodes Detected by PET/CT in a Metastatic Survey of Lung Cancer

  2016cites this paper
• MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer

  2016cites this paper
• Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt

  2016cites this paper
• Association between [F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer

  2015cites this paper
• Association between [ 18 F ]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1 α and glucose transporter 1 in non-small cell lung cancer

  2015cites this paper
• Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT

  2015cites this paper
• Variation in 18F-FDG PET findings in a patient with synchronous multiple thymoma

  2015cites this paper
• Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer

  2015cites this paper
• Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?

  2015cites this paper
• In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

  2015cites this paper
• Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.

  2014cites this paper
• Functional Imaging of Insulitis in Type 1 Diabetes

  2014cites this paper
• High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

  2014cites this paper
• Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [18F] FDG-PET imaging combined with proteomic approaches

  2014cites this paper
• Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

  2014cites this paper
• Prediction of recurrence for non-small cell lung cancer by combined analysis of molecular markers and 18F 2-fluoro-2-deoxy-D-glucose positron emission tomography.

  2014cites this paper
• Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma

  2014cites this paper
• Correlação da expressão de GLUT1, HK1, HK2 e HK3 com alta captação de 18 F-FDG em hiperplasia

  2014cites this paper
• The Basic Principles of FDG-PET/CT Imaging.

  2014cites this paper
• Hyperpolarized [1-13C]Dehydroascorbate MR Spectroscopy in a Murine Model of Prostate Cancer: Comparison with 18F-FDG PET

  2013cites this paper
• PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III–IV Non–Small Cell Lung Cancer Patients

  2013cites this paper
• Non–FDG-Avid Primary Papillary Thyroid Carcinoma May Not Differ from FDG-Avid Papillary Thyroid Carcinoma

  2013cites this paper
• Exogenous expression of human SGLT1 exhibits aggregations in sodium dodecyl sulfate polyacrylamide gel electrophoresis.

  2013cites this paper
• Clinical importance of [18F]fluorodeoxyglucose positron emission tomography/computed tomography in the management of patients with bronchoalveolar carcinoma: Role in the detection of recurrence

  2013influential citation
• Adenosquamous Carcinoma of the Lung: CT, FDG PET, and Clinicopathologic Findings

  2013cites this paper
• Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation

  2013cites this paper
• Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer

  2013cites this paper
• Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging

  2013cites this paper
• Metformin: the hidden chronicles of a magic drug.

  2013cites this paper
• Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.

  2013cites this paper
• Original Article Exogenous expression of human SGLT1 exhibits aggregations in sodium dodecyl sulfate polyacrylamide gel electrophoresis

  2013cites this paper
• Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.

  2013cites this paper
• Towards Biological Target Volumes Definition for Radiotherapy Treatment Planning: Quo Vadis PET/CT?

  2013cites this paper
• SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.

  2013cites this paper
• Erratum to: Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging

  2013cites this paper
• in a Murine Model of Prostate Cancer: Comparison with 18 F-FDG PET

  2013cites this paper
• Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.

  2012cites this paper
• ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.

  2012cites this paper
• Correlation between glucose transporter type-1 expression and 18F-FDG uptake on PET in oral cancer

  2012cites this paper
• RETRACTED ARTICLE: Relationship between 18F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer

  2012cites this paper
• Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma

  2012cites this paper
• Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.

  2012cites this paper
• Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.

  2012cites this paper
• Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.

  2012cites this paper